ZA946767B - Monocional antibodies having property of causing apoptosis. - Google Patents
Monocional antibodies having property of causing apoptosis.Info
- Publication number
- ZA946767B ZA946767B ZA946767A ZA946767A ZA946767B ZA 946767 B ZA946767 B ZA 946767B ZA 946767 A ZA946767 A ZA 946767A ZA 946767 A ZA946767 A ZA 946767A ZA 946767 B ZA946767 B ZA 946767B
- Authority
- ZA
- South Africa
- Prior art keywords
- antibody
- property
- myelocytic
- causing apoptosis
- apoptosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05242110 | 1993-09-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA946767B true ZA946767B (en) | 1995-04-03 |
Family
ID=17084452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA946767A ZA946767B (en) | 1993-09-03 | 1994-09-02 | Monocional antibodies having property of causing apoptosis. |
Country Status (19)
Country | Link |
---|---|
US (4) | US5840344A (zh) |
EP (1) | EP0721015B1 (zh) |
KR (1) | KR100241863B1 (zh) |
CN (1) | CN1046314C (zh) |
AT (1) | ATE280835T1 (zh) |
AU (1) | AU692466B2 (zh) |
CA (1) | CA2169950A1 (zh) |
CZ (1) | CZ294359B6 (zh) |
DE (1) | DE69434097T2 (zh) |
FI (1) | FI960567A (zh) |
HU (1) | HU222989B1 (zh) |
NO (1) | NO960684D0 (zh) |
PL (1) | PL181783B1 (zh) |
RU (1) | RU2202615C2 (zh) |
SK (1) | SK281964B6 (zh) |
TW (1) | TW426687B (zh) |
UA (1) | UA50708C2 (zh) |
WO (1) | WO1995006748A1 (zh) |
ZA (1) | ZA946767B (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA946767B (en) * | 1993-09-03 | 1995-04-03 | Chugai Pharmaceutical Co Ltd | Monocional antibodies having property of causing apoptosis. |
AU2232597A (en) | 1996-03-06 | 1997-09-22 | Chugai Seiyaku Kabushiki Kaisha | Method of screening apoptosis inducing substances |
ES2242227T5 (es) | 1996-07-15 | 2011-12-09 | Chugai Seiyaku Kabushiki Kaisha | Nuevo factor de tipo vegf. |
DE69839492D1 (de) * | 1997-09-11 | 2008-06-26 | Chugai Pharmaceutical Co Ltd | Monoklonale antikörper zur apoptosis-induzierung |
US7531643B2 (en) | 1997-09-11 | 2009-05-12 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibody inducing apoptosis |
US7696325B2 (en) | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
EP1167388A4 (en) * | 1999-03-10 | 2002-05-29 | Chugai Pharmaceutical Co Ltd | APOPTOSE INDUCING SINGLE STRING FV |
US20040058393A1 (en) * | 2000-04-17 | 2004-03-25 | Naoshi Fukishima | Agonist antibodies |
EP2351838A1 (en) * | 2000-10-20 | 2011-08-03 | Chugai Seiyaku Kabushiki Kaisha | Crosslinking agonistic antibodies |
JPWO2002033072A1 (ja) | 2000-10-20 | 2004-02-26 | 中外製薬株式会社 | 低分子化tpoアゴニスト抗体 |
US7195771B1 (en) | 2000-11-21 | 2007-03-27 | Kimberly-Clark Worldwide, Inc. | Water-soluble lotions for paper products |
WO2003044482A2 (en) * | 2001-11-16 | 2003-05-30 | The University Of Tennessee Research Corporation | Recombinant antibody fusion proteins and methods for detection of apoptotic cells |
ATE414105T1 (de) | 2002-10-11 | 2008-11-15 | Chugai Pharmaceutical Co Ltd | Zelltod-induzierender wirkstoff |
JP2004279086A (ja) * | 2003-03-13 | 2004-10-07 | Konica Minolta Holdings Inc | 放射線画像変換パネル及び放射線画像変換パネルの製造方法 |
JPWO2004087763A1 (ja) * | 2003-03-31 | 2006-07-27 | 中外製薬株式会社 | Cd22に対する改変抗体およびその利用 |
TW200530269A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
US20070280951A1 (en) * | 2003-12-12 | 2007-12-06 | Naoki Kimura | Cell Death Inducing Agents |
TW200530266A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Method of reinforcing antibody activity |
US20070281327A1 (en) * | 2003-12-12 | 2007-12-06 | Kiyotaka Nakano | Methods of Screening for Modified Antibodies With Agonistic Activities |
JP5057967B2 (ja) | 2005-03-31 | 2012-10-24 | 中外製薬株式会社 | sc(Fv)2構造異性体 |
JPWO2006123724A1 (ja) * | 2005-05-18 | 2008-12-25 | 国立大学法人徳島大学 | 抗hla抗体を利用した新規医薬品 |
CN101262885B (zh) | 2005-06-10 | 2015-04-01 | 中外制药株式会社 | 含有sc(Fv)2的药物组合物 |
AU2006256041B2 (en) * | 2005-06-10 | 2012-03-29 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
US20080038237A1 (en) * | 2006-02-28 | 2008-02-14 | Sapolsky Robert M | Trojan horse immunotherapy |
US20100150927A1 (en) * | 2006-07-13 | 2010-06-17 | Chugai Seiyaku Kabushiki Kaisha | Cell death inducer |
CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
JP7174522B2 (ja) | 2014-12-05 | 2022-11-17 | メモリアル スローン ケタリング キャンサー センター | Fc受容体様5を標的とするキメラ抗原受容体およびその使用 |
MX2018006787A (es) | 2015-12-04 | 2018-11-09 | Memorial Sloan Kettering Cancer Center | Anticuerpos que dirigen al receptor fc similar a 5 y metodos de uso. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA946767B (en) * | 1993-09-03 | 1995-04-03 | Chugai Pharmaceutical Co Ltd | Monocional antibodies having property of causing apoptosis. |
AU2232597A (en) * | 1996-03-06 | 1997-09-22 | Chugai Seiyaku Kabushiki Kaisha | Method of screening apoptosis inducing substances |
DE69839492D1 (de) * | 1997-09-11 | 2008-06-26 | Chugai Pharmaceutical Co Ltd | Monoklonale antikörper zur apoptosis-induzierung |
EP1167388A4 (en) * | 1999-03-10 | 2002-05-29 | Chugai Pharmaceutical Co Ltd | APOPTOSE INDUCING SINGLE STRING FV |
-
1994
- 1994-09-02 ZA ZA946767A patent/ZA946767B/xx unknown
- 1994-09-02 KR KR1019960700821A patent/KR100241863B1/ko not_active IP Right Cessation
- 1994-09-02 WO PCT/JP1994/001453 patent/WO1995006748A1/ja active IP Right Grant
- 1994-09-02 UA UA96030813A patent/UA50708C2/uk unknown
- 1994-09-02 PL PL94313260A patent/PL181783B1/pl not_active IP Right Cessation
- 1994-09-02 AT AT94925618T patent/ATE280835T1/de not_active IP Right Cessation
- 1994-09-02 CN CN94193260A patent/CN1046314C/zh not_active Expired - Fee Related
- 1994-09-02 AU AU75466/94A patent/AU692466B2/en not_active Ceased
- 1994-09-02 EP EP94925618A patent/EP0721015B1/en not_active Expired - Lifetime
- 1994-09-02 RU RU96107203/13A patent/RU2202615C2/ru not_active IP Right Cessation
- 1994-09-02 SK SK255-96A patent/SK281964B6/sk unknown
- 1994-09-02 US US08/605,059 patent/US5840344A/en not_active Expired - Lifetime
- 1994-09-02 CA CA002169950A patent/CA2169950A1/en not_active Abandoned
- 1994-09-02 HU HU9600206A patent/HU222989B1/hu not_active IP Right Cessation
- 1994-09-02 DE DE69434097T patent/DE69434097T2/de not_active Expired - Fee Related
- 1994-09-02 CZ CZ1996617A patent/CZ294359B6/cs not_active IP Right Cessation
- 1994-11-19 TW TW083110887A patent/TW426687B/zh not_active IP Right Cessation
-
1996
- 1996-02-07 FI FI960567A patent/FI960567A/fi not_active Application Discontinuation
- 1996-02-21 NO NO960684A patent/NO960684D0/no not_active Application Discontinuation
-
1998
- 1998-09-17 US US09/154,498 patent/US6267959B1/en not_active Expired - Lifetime
-
2000
- 2000-12-15 US US09/736,146 patent/US6759043B2/en not_active Expired - Fee Related
-
2003
- 2003-03-03 US US10/376,628 patent/US20030147894A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FI960567A0 (fi) | 1996-02-07 |
CA2169950A1 (en) | 1995-03-09 |
RU2202615C2 (ru) | 2003-04-20 |
SK281964B6 (sk) | 2001-09-11 |
EP0721015B1 (en) | 2004-10-27 |
TW426687B (en) | 2001-03-21 |
FI960567A (fi) | 1996-02-07 |
US6267959B1 (en) | 2001-07-31 |
DE69434097D1 (de) | 2004-12-02 |
AU692466B2 (en) | 1998-06-11 |
PL313260A1 (en) | 1996-06-24 |
NO960684L (no) | 1996-02-21 |
WO1995006748A1 (fr) | 1995-03-09 |
SK25596A3 (en) | 1996-10-02 |
US5840344A (en) | 1998-11-24 |
UA50708C2 (uk) | 2002-11-15 |
PL181783B1 (pl) | 2001-09-28 |
CZ61796A3 (en) | 1996-06-12 |
CN1046314C (zh) | 1999-11-10 |
EP0721015A1 (en) | 1996-07-10 |
ATE280835T1 (de) | 2004-11-15 |
AU7546694A (en) | 1995-03-22 |
EP0721015A4 (en) | 1999-03-31 |
DE69434097T2 (de) | 2006-02-02 |
CN1130405A (zh) | 1996-09-04 |
US20030147894A1 (en) | 2003-08-07 |
CZ294359B6 (cs) | 2004-12-15 |
HU9600206D0 (en) | 1996-03-28 |
HUT74594A (en) | 1997-01-28 |
NO960684D0 (no) | 1996-02-21 |
US6759043B2 (en) | 2004-07-06 |
HU222989B1 (hu) | 2004-01-28 |
KR100241863B1 (ko) | 2000-03-02 |
US20010001712A1 (en) | 2001-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA946767B (en) | Monocional antibodies having property of causing apoptosis. | |
ES2106195T3 (es) | Anticuerpo igg aglicosilado anti cd3. | |
FI961285A (fi) | CD40:n vasta-aineita | |
NO2006008I2 (no) | Natalizumab, anti alfa-4 integrin humanized monoclonal antibody | |
DK0742795T3 (da) | Immunstimulerende monoklonale antistoffer | |
DE3586216D1 (de) | Brusttumorassoziiertes antigen und monoklonale antikoerper dazu. | |
NO973875L (no) | Fremgangsmåte for stimulering av en immunrespons | |
WO1995024481A3 (en) | Humanized monoclonal antibodies against human interleukin-4 | |
ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
EP0287397A3 (en) | Monoclonal antibody specific to human pancreatic phospholipase a2 | |
DE3580482D1 (de) | Monoklonale antikoerper und immunisierung damit. | |
AU1493995A (en) | Monoclonal antibody | |
ITRM920223A0 (it) | Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf. | |
DE69118702D1 (de) | Neue verwendung eines monoklonalen antikörpers | |
ES2051870T3 (es) | Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t. | |
AU6162794A (en) | Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor | |
ATE58173T1 (de) | Monoklonale antikoerper und immunisierung damit. |